—

TANAKA CAPITAL MANAGEMENT INC

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    44

  • Value ($000)

    $60

  • Date Filed
    05/18/2026
  • Form type
    13F-HR
  • CIK
    0000816788
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
U
UAMY

United States Antimony

COM
911549103
$5.38K
9 %

615,975

N
NXE

NexGen Energy

COM
65340P106
$5.1K
9 %

439,205

H
HTD

Corcept Therapeutics

COM
218352102
$4.47K
8 %

110,854

N
NVDA

Nvidia

COM
67066G104
$4.32K
7 %

24,780

---

Aura Minerals, Inc.

COM
G06973104
$4.09K
7 %

50,085

N
NUVB

Nuvation Bio Inc.

COM
67080N101
$3.87K
7 %

901,825

A
AAPL

Apple Computing

COM
037833100
$3.26K
5 %

12,859

I
IJR

Intellia Therapeutics

COM
464287804
$2.82K
5 %

220,107

C
CPRX

Catalyst Pharmaceuticals

COM
14888U101
$2.81K
5 %

113,418

O
ONTO

Onto Innovation

COM
683344105
$2.55K
4 %

12,448

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 44